The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VYCO · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | VYCO | NOC | DXCM | AME |
|---|---|---|---|---|
| Moat Score (0–100) | 74 (highest) | 74 (highest) | 74 (highest) | 73 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 70 | 77 | 80 (highest) | 80 (highest) |
| Pricing power | 100 (highest) | 90 | 98 | 60 |
| Returns on capital | — | 76 | 96 (highest) | 54 |
| Balance-sheet safety | 100 (highest) | 41 | 73 | 89 |
| Capital discipline | 24 | 87 (highest) | 24 | 80 |
| Price vs. high estimate | No price data | 12% above high estimate (largest discount to high estimate) | 199% above high estimate | 98% above high estimate |
| Market cap | $2.3M | $74.4B | $29.1B | $53.9B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |